600056 中國醫藥
按盤價 
11.650 +0.030 (+0.258%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 25,894,435 | -3.42% | 34,148,360 | 38,824,431 | 37,592,650 | 36,234,415 | |
| 減：營業總成本 | 24,983,222 | -3.54% | 32,983,445 | 37,501,895 | 36,137,940 | 34,480,964 | |
| 其中:營業成本 | 23,203,637 | -3.13% | 30,489,594 | 34,440,814 | 32,845,786 | 31,018,239 | |
| 財務費用 | 35,014 | -74.95% | 195,924 | 112,038 | 138,317 | 221,691 | |
| 資產減值損失 | (62) | -105.43% | (175,326) | (13,539) | (280,660) | (575,297) | |
| 公允價值變動收益 | 5,891 | -631.44% | 127,467 | 985 | 1,922 | (2,135) | |
| 投資收益 | 12,900 | 117.24% | (65,017) | (15,792) | 51,001 | 43,657 | |
| 其中：對聯營企業和合營企業的投資收益 | 41,389 | 17.75% | 18,736 | 77,043 | 93,219 | 113,900 | |
| 營業利潤 | 823,763 | -6.18% | 931,568 | 1,672,334 | 1,199,698 | 937,135 | |
| 利潤總額 | 822,448 | -5.49% | 953,189 | 1,640,556 | 1,196,127 | 940,106 | |
| 減：所得稅費用 | 233,737 | 6.46% | 266,565 | 398,435 | 307,699 | 225,830 | |
| 淨利潤 | 588,711 | -9.52% | 686,624 | 1,242,120 | 888,428 | 714,276 | |
| 減：非控股權益 | 133,947 | -22.93% | 151,156 | 194,081 | 152,827 | 67,219 | |
| 股東淨利潤 | 454,764 | -4.64% | 535,468 | 1,048,039 | 735,601 | 647,057 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.304 | -4.64% | 0.358 | 0.701 | 0.492 | 0.433 | |
| 每股派息 (元) * | 0.020 | -9.57% | 0.107 | 0.210 | 0.148 | 0.182 | |
| 每股淨資產 (元) * | 7.924 | 1.68% | 7.902 | 7.728 | 7.230 | -- | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 14/11/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
